Healthcare products are included in the shipments leaving Chengdu for Poland and beyond
Much of the time, “cold chain” refers, at least for pharmaceuticals, to preventing overheating of products en route from manufacturer to distribution points, but in western China, at this time of year, the problem is the reverse: outside temperatures can reach as low as -20C. As part of an overall trade lane from China to Europe, DHL Global Forwarding has developed a temperature-controlled railcar service that can keep products with a specified range between -25 and +25°C. The containers are individually powered, and designed to fit into normal train schedules. Clients can monitor and modify temperatures remotely and track the shipment through DHL’s communications systems.
DHL says that its multimodal customers (which includes electronics, healthcare products and consumer goods) benefit from a dependable rail service that is cheaper than air freight, but with half the delivery time of ocean freight. “We launched this precise climate-control rail solution earlier in the year after rigorous trials and tests,” said Kelvin Leung, CEO, DHL Global Forwarding Asia Pacific (Singapore). “Customer interest in this innovative service has been robust.”
DHL’s trade lane runs from Chengdu (where, the company says, 262 of the Fortune 500 have offices) to DHL's intermodal hubs in Małaszewicze and Lodz, Poland. Earlier, the company’s DHL Supply Chain unit announced a significant expansion of its China facilities, including a new logistics center in Chengdu of 54,000-sq. m. capacity. The center also acts as a crossdock facility for transportation across the western region of China.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.